Related Articles
Significance of PD‑L1 clones and C‑MET expression in hepatocellular carcinoma
Tumor microenvironment immune types in gastric cancer are associated with mismatch repair however, not HER2 status
MicroRNAs aid the assessment of programmed death ligand 1 expression in patients with non‑small cell lung cancer
High farnesoid X receptor expression predicts favorable clinical outcomes in PD‑L1<sup>low/negative</sup> non‑small cell lung cancer patients receiving anti‑PD‑1‑based chemo‑immunotherapy
Mechanistic insight of predictive biomarkers for antitumor PD‑1/PD‑L1 blockade: A paradigm shift towards immunome evaluation (Review)